Snowden Capital Advisors’s Intuitive Surgical ISRG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.68M | Sell |
7,988
-473
| -6% | -$239K | 0.1% | 209 |
|
|
2025
Q4 | $4.79M | Buy |
8,461
+974
| +13% | +$519K | 0.12% | 174 |
|
|
2025
Q3 | $3.35M | Sell |
7,487
-1,511
| -17% | -$725K | 0.09% | 226 |
|
|
2025
Q2 | $4.89M | Buy |
8,998
+932
| +12% | +$487K | 0.14% | 157 |
|
|
2025
Q1 | $3.99M | Buy |
8,066
+470
| +6% | +$260K | 0.13% | 175 |
|
|
2024
Q4 | $3.96M | Sell |
7,596
-533
| -7% | -$278K | 0.12% | 179 |
|
|
2024
Q3 | $3.99M | Sell |
8,129
-851
| -9% | -$396K | 0.12% | 204 |
|
|
2024
Q2 | $3.99M | Sell |
8,980
-2,399
| -21% | -$955K | 0.12% | 208 |
|
|
2024
Q1 | $4.54M | Buy |
11,379
+1,913
| +20% | +$723K | 0.14% | 192 |
|
|
2023
Q4 | $3.19M | Sell |
9,466
-1,362
| -13% | -$406K | 0.12% | 217 |
|
|
2023
Q3 | $3.16M | Sell |
10,828
-3,135
| -22% | -$979K | 0.13% | 210 |
|
|
2023
Q2 | $4.77M | Buy |
13,963
+101
| +0.7% | +$30.6K | 0.17% | 160 |
|
|
2023
Q1 | $3.54M | Sell |
13,862
-61
| -0.4% | -$15K | 0.14% | 194 |
|
|
2022
Q4 | $3.69M | Buy |
13,923
+159
| +1% | +$38.8K | 0.15% | 162 |
|
|
2022
Q3 | $2.58M | Sell |
13,764
-1,548
| -10% | -$332K | 0.12% | 212 |
|
|
2022
Q2 | $3.07M | Buy |
15,312
+4,216
| +38% | +$989K | 0.14% | 190 |
|
|
2022
Q1 | $3.35M | Buy |
11,096
+3,714
| +50% | +$1.09M | 0.13% | 196 |
|
|
2021
Q4 | $2.65M | Sell |
7,382
-3,661
| -33% | -$1.26M | 0.14% | 197 |
|
|
2021
Q3 | $3.66M | Sell |
11,043
-2,982
| -21% | -$1M | 0.18% | 163 |
|
|
2021
Q2 | $4.3M | Buy |
14,025
+1,401
| +11% | +$393K | 0.22% | 140 |
|
|
2021
Q1 | $3.11M | Sell |
12,624
-2,292
| -15% | -$577K | 0.18% | 182 |
|
|
2020
Q4 | $4.07M | Buy |
14,916
+1,890
| +15% | +$469K | 0.27% | 106 |
|
|
2020
Q3 | $3.08M | Sell |
13,026
-1,221
| -9% | -$274K | 0.25% | 132 |
|
|
2020
Q2 | $2.71M | Buy |
14,247
+324
| +2% | +$58.1K | 0.23% | 142 |
|
|
2020
Q1 | $2.3M | Sell |
13,923
-7,422
| -35% | -$1.36M | 0.25% | 127 |
|
|
2019
Q4 | $4.21M | Buy |
21,345
+3,285
| +18% | +$615K | 0.37% | 73 |
|
|
2019
Q3 | $3.25M | Buy |
18,060
+39
| +0.2% | +$6.75K | 0.33% | 98 |
|
|
2019
Q2 | $3.15M | Buy |
18,021
+1,359
| +8% | +$233K | 0.32% | 99 |
|
|
2019
Q1 | $3.17M | Buy |
16,662
+36
| +0.2% | +$6.4K | 0.35% | 87 |
|
|
2018
Q4 | $2.65M | Sell |
16,626
-27
| -0.2% | -$4.58K | 0.34% | 90 |
|
|
2018
Q3 | $3.19M | Buy |
16,653
+288
| +2% | +$51.1K | 0.36% | 71 |
|
|
2018
Q2 | $2.61M | Buy |
16,365
+171
| +1% | +$26.1K | 0.34% | 82 |
|
|
2018
Q1 | $2.23M | Buy |
16,194
+177
| +1% | +$24.7K | 0.33% | 103 |
|
|
2017
Q4 | $1.95M | Buy |
16,017
+258
| +2% | +$32.3K | 0.28% | 114 |
|
|
2017
Q3 | $1.83M | Buy |
15,759
+108
| +0.7% | +$11.8K | 0.3% | 103 |
|
|
2017
Q2 | $1.63M | Buy |
15,651
+1,323
| +9% | +$127K | 0.31% | 111 |
|
|
2017
Q1 | $1.22M | Buy |
+14,328
| New | +$1.13M | 0.27% | 128 |
|
Other funds holding ISRG
VCM
VPM
Snowden Capital Advisors's ISRG Position: Q1 2026 in Review
Snowden Capital Advisors reduced its Intuitive Surgical (ISRG) stake by 5.6% in Q1 2026, selling an estimated $239K and leaving 7,988 shares worth $3.68M. The position accounts for 0.1% of the portfolio, ranked #209.
Snowden Capital Advisors first reported a position in ISRG in Q1 2017 and has held it in 37 quarters since. The position peaked at $4.89M in Q2 2025. 2,303 funds tracked by Wall St. Rank hold ISRG as of Q1 2026.
- Snowden Capital Advisors held 7,988 shares of Intuitive Surgical worth $3.68M as of Q1 2026.
- Snowden Capital Advisors sold 473 Intuitive Surgical shares in Q1 2026, an estimated $239K.
- Intuitive Surgical made up 0.1% of Snowden Capital Advisors's portfolio in Q1 2026, its #209 holding.
- Snowden Capital Advisors first reported a position in Intuitive Surgical in Q1 2017 and has held it in 37 quarters since.
- Snowden Capital Advisors's Intuitive Surgical position peaked at $4.89M in Q2 2025.
- 2,303 funds tracked by Wall St. Rank held Intuitive Surgical as of Q1 2026.
Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.